ArticleBioorganic & medicinal chemistry2022

Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation.

Changwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.